RT Journal Article
SR Electronic
T1 Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic Exenteration
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 5149
OP 5153
DO 10.21873/anticanres.16715
VO 43
IS 11
A1 KOJI KOMORI
A1 TSUTOMU TANAKA
A1 YOSHITAKA INABA
A1 TAKASHI KINOSHITA
A1 YUSUKE SATO
A1 AKIRA OUCHI
A1 SEIJI ITO
A1 TETSUYA ABE
A1 KAZUNARI MISAWA
A1 YUICHI ITO
A1 SEIJI NATSUME
A1 EIJI HIGAKI
A1 TOMONARI ASANO
A1 MASATAKA OKUNO
A1 HIRONORI FUJIEDA
A1 SATORU AKAZA
A1 HISAHUMI SAITO
A1 KIYOSHI NARITA
A1 TAKUYA KITAHARA
A1 TAKAAKI HANAZAWA
A1 HIDENORI OJIO
A1 MASASHI NEGITA
A1 YASUHIRO SHIMIZU
YR 2023
UL http://ar.iiarjournals.org/content/43/11/5149.abstract
AB Background/Aim: Hyperchloremic metabolic acidosis after total pelvic exenteration (TPE) is relatively rare. Urinary diversion of the ileal conduit during TPE can result in increased urine reabsorption leading to hyperchloremic metabolic acidosis. We developed a new technique for the retrograde catheterization of a ureteral stent into an ileal conduit to treat hyperchloremic metabolic acidosis. Case Report: A 70-year-old man underwent TPE for locally recurrent rectal cancer. Multiple episodes of complications, such as hyperchloremia and metabolic acidosis, occurred. Effective drainage of urine from the ileal conduit is crucial. With collaboration between an endoscopist and a radiologist, we developed a novel method for retrograde catheterization of the ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis after TPE. The patient’s condition quickly improved after the procedure. Conclusion: Our novel technique of retrograde catheterization of a ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis could be adopted worldwide, as it is effective and safe.